CVS Health Statistics

Total Valuation

CVS Health has a market cap or net worth of EUR 85.60 billion. The enterprise value is 144.86 billion.

Market Cap	85.60B
Enterprise Value	144.86B

Important Dates

The next estimated earnings date is Wednesday, May 6, 2026.

Earnings Date	May 6, 2026
Ex-Dividend Date	Apr 23, 2026

Share Statistics

Current Share Class	1.28B
Shares Outstanding	n/a
Shares Change (YoY)	+0.71%
Shares Change (QoQ)	+0.63%
Owned by Insiders (%)	0.10%
Owned by Institutions (%)	88.95%
Float	1.28B

Valuation Ratios

The trailing PE ratio is 56.85 and the forward PE ratio is 10.90.

PE Ratio	56.85
Forward PE	10.90
PS Ratio	0.25
PB Ratio	1.33
P/TBV Ratio	n/a
P/FCF Ratio	12.87
P/OCF Ratio	9.45
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.63, with an EV/FCF ratio of 21.79.

EV / Earnings	96.20
EV / Sales	0.43
EV / EBITDA	9.63
EV / EBIT	16.96
EV / FCF	21.79

Financial Position

The company has a current ratio of 0.84, with a Debt / Equity ratio of 1.06.

Current Ratio	0.84
Quick Ratio	0.57
Debt / Equity	1.06
Debt / EBITDA	4.53
Debt / FCF	10.24
Interest Coverage	3.21

Financial Efficiency

Return on equity (ROE) is 2.29% and return on invested capital (ROIC) is 5.62%.

Return on Equity (ROE)	2.29%
Return on Assets (ROA)	2.47%
Return on Invested Capital (ROIC)	5.62%
Return on Capital Employed (ROCE)	6.08%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.31M
Profits Per Employee	5,803
Employee Count	300,000
Asset Turnover	1.58
Inventory Turnover	18.56

Taxes

In the past 12 months, CVS Health has paid 347.49 million in taxes.

Income Tax	347.49M
Effective Tax Rate	19.10%

Stock Price Statistics

The stock price has increased by +17.45% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+17.45%
50-Day Moving Average	65.31
200-Day Moving Average	64.49
Relative Strength Index (RSI)	59.72
Average Volume (20 Days)	260

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.26

Income Statement

In the last 12 months, CVS Health had revenue of EUR 340.54 billion and earned 1.51 billion in profits. Earnings per share was 1.18.

Revenue	340.54B
Gross Profit	45.25B
Operating Income	8.53B
Pretax Income	1.82B
Net Income	1.51B
EBITDA	12.46B
EBIT	8.53B
Earnings Per Share (EPS)	1.18

Balance Sheet

The company has 9.03 billion in cash and 68.09 billion in debt, giving a net cash position of -59.07 billion.

Cash & Cash Equivalents	9.03B
Total Debt	68.09B
Net Cash	-59.07B
Net Cash Per Share	n/a
Equity (Book Value)	64.20B
Book Value Per Share	50.40
Working Capital	-11.91B

Cash Flow

In the last 12 months, operating cash flow was 9.06 billion and capital expenditures -2.41 billion, giving a free cash flow of 6.65 billion.

Operating Cash Flow	9.06B
Capital Expenditures	-2.41B
Depreciation & Amortization	3.93B
Net Borrowing	-1.52B
Free Cash Flow	6.65B
FCF Per Share	n/a

Margins

Gross margin is 13.29%, with operating and profit margins of 2.51% and 0.44%.

Gross Margin	13.29%
Operating Margin	2.51%
Pretax Margin	0.53%
Profit Margin	0.44%
EBITDA Margin	3.66%
EBIT Margin	2.51%
FCF Margin	1.95%

Dividends & Yields

This stock pays an annual dividend of 2.28, which amounts to a dividend yield of 3.39%.

Dividend Per Share	2.28
Dividend Yield	3.39%
Dividend Growth (YoY)	-6.73%
Years of Dividend Growth	n/a
Payout Ratio	192.28%
Buyback Yield	-0.71%
Shareholder Yield	2.71%
Earnings Yield	1.76%
FCF Yield	7.77%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CVS Health has an Altman Z-Score of 2.27 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.27
Piotroski F-Score	7